Literature DB >> 3437921

Tianeptine, a selective enhancer of serotonin uptake in rat brain.

T Mennini1, E Mocaer, S Garattini.   

Abstract

Tianeptine is a tricyclic agent provided with antidepressant activity in experimental models and in clinical trials. In vitro tianeptine and its two principal metabolites have no effects on monoamine uptake, release or neurotransmitter receptor binding. The biochemical effect of tianeptine in vivo after acute or repeated treatment indicates an enhanced serotonin uptake in cortex and hippocampus but not in mesencephalon, with no effect on noradrenaline or dopamine uptake. This enhanced serotonin uptake is not due to decrease in serotonin release, but is related to increase in the Vmax of the uptake carrier for serotonin. The fact that enhancers as well as inhibitors of serotonin uptake are provided with antidepressant activity challenge simple conclusion as to their mechanism of action. The possibility that increased serotonin uptake after repeated treatment may be related to the antidepressant activity exerted by these drugs, and drugs enhancing serotonin uptake might have antidepressant activity, with an earlier onset, is proposed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437921     DOI: 10.1007/BF00169302

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states.

Authors:  D A Greenberg; D C Prichard; S H Snyder
Journal:  Life Sci       Date:  1976-07-01       Impact factor: 5.037

2.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.

Authors:  D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

3.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.

Authors:  E G GRAY; V P WHITTAKER
Journal:  J Anat       Date:  1962-01       Impact factor: 2.610

4.  Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin.

Authors:  T Mennini; E Borroni; R Samanin; S Garattini
Journal:  Neurochem Int       Date:  1981       Impact factor: 3.921

5.  Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.

Authors:  I Creese; T Prosser; S H Synder
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

6.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

7.  Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.

Authors:  B Manias; D A Taylor
Journal:  Eur J Pharmacol       Date:  1983-11-25       Impact factor: 4.432

8.  Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding.

Authors:  R Raisman; M S Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1980-02       Impact factor: 4.432

9.  Effect of long term amineptine treatment on pre- and postsynaptic mechanisms in rat brain.

Authors:  A Ceci; S Garattini; M Gobbi; T Mennini
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

10.  Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.

Authors:  M L Barbaccia; O Gandolfi; D M Chuang; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  33 in total

Review 1.  Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake.

Authors:  Graziano Pinna; Erminio Costa; Alessandro Guidotti
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

2.  Discriminative stimulus properties of tianeptine.

Authors:  Tevfik Alici; Hakan Kayir; M Oguz Aygoren; Esra Saglam; I Tayfun Uzbay
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

Review 3.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 4.  Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence.

Authors:  N Andrews; S E File
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Pharmacokinetic and pharmacodynamic interaction between the antidepressant tianeptine and oxazepam at steady-state.

Authors:  S Toon; B L Holt; S J Langley; F G Mullins; M Rowland; M S Halliday; C Salvadori; B Delalleau
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.

Authors:  R Zini; D Morin; C Salvadori; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

7.  Tianeptine and its main metabolite pharmacokinetics in chronic alcoholism and cirrhosis.

Authors:  R J Royer; M J Royer-Morrot; F Paille; D Barrucand; J Schmitt; R Defrance; C Salvadori
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

8.  Effect of prenatal exposure to tianeptine on different neurotransmitter receptors and 5-HT-stimulated inositol phosphate formation in rat brain.

Authors:  G Romero; E Toscano; D Montero; M C De Felipe; J Del Rio
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

Review 10.  The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.

Authors:  B S McEwen; S Chattarji; D M Diamond; T M Jay; L P Reagan; P Svenningsson; E Fuchs
Journal:  Mol Psychiatry       Date:  2009-08-25       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.